US Vaccine Panel Pauses mRNA Covid Review Amid Republican Concerns

In Brief

A federal vaccine advisory panel has halted its review of Covid-19 mRNA guidance, The Guardian reports.

Key Facts

• A major federal panel advising on vaccines has stepped back from reviewing Covid-19 mRNA vaccine guidance.
• The decision follows reported concerns from some Republicans about the political impact before upcoming midterm elections.
• Several advisers to RFK Jr were involved in the initial plan to end federal guidance, according to The Guardian.

What Happened

A federal advisory panel on vaccines has retreated from efforts to change federal guidance on Covid-19 mRNA vaccines, reportedly after Republican concerns about potential political consequences ahead of midterm elections.

Why It Matters

The panel's decision may affect ongoing debates about Covid-19 vaccine policy and its intersection with political considerations. The involvement of advisers to RFK Jr highlights the role of various stakeholders in vaccine guidance discussions. Based on a single source report

What's Next

It is unclear if or when the panel will revisit its review of mRNA Covid-19 vaccine guidance. Observers may monitor further statements from the panel or political leaders regarding future vaccine policy changes.